Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Extraction of technetium-99m by some organic solvents from macro scale molybdenum solution.

Hayato Ikeda, Yoshihiko Hayashi, Naruto Takahashi, Kozi Nakai, Atsushi Shinohara, Tadashi Watabe, Yasukazu Kanai, Hiroki Kato, Eku Shimosegawa and Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1119;
Hayato Ikeda
2Department of Nuclear Medicine and Tracer Kinetics Graduate School of Medicine, Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiko Hayashi
4Department of Chemistry Graduate School of Science, Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naruto Takahashi
4Department of Chemistry Graduate School of Science, Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kozi Nakai
4Department of Chemistry Graduate School of Science, Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Shinohara
4Department of Chemistry Graduate School of Science, Osaka University Toyonaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
2Department of Nuclear Medicine and Tracer Kinetics Graduate School of Medicine, Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasukazu Kanai
1Department of Molecular Imaging in Medicine Graduate School of Medicine, Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Kato
2Department of Nuclear Medicine and Tracer Kinetics Graduate School of Medicine, Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eku Shimosegawa
1Department of Molecular Imaging in Medicine Graduate School of Medicine, Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
5Osaka University Immunology Frontier Research Center Suita Japan
3Department of Nuclear Medicine and Tracer Kinetics Graduate School of Medicine, Osaka University Suita, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1119

Objectives Molybdenum-99(99Mo)/Techtetium-99m(99mTc) is generally produced by a nuclear reactor. We studied the method to obtain enough activity of 99mTc for nuclear medicine using a cyclotron. In the previous work, we demonstrated that 99mTc was extracted with methyl ethyl ketone (MEK) efficiently from the aqueous solution dissolved macro amount of MoO3. However, it was found that the considerable amounts of Mo were contaminated into the organic phase. One of the reason is high dissolvability of MEK to water (29 g/100 mL water; 20°C). We examined the extraction of 99mTc from the 99Mo/99mTc aqueous solution with several organic solvents (ethyl acetate, diethyl ether, hexane, carbon tetrachloride, chloroform, dichloromethane). Further the contamination of Mo in the organic solvents was discussed.

Methods We selected some organic phases (ethyl acetate, diethyl ether, hexane, carbon tetrachloride, chloroform, dichloromethane). We prepared 500 mL of molybdenum stock solution (included 2 M NaOH and 167 g MoO3). After extraction, the organic phases were evaporated and prepared to detect molybdenum concentration by ICP-AES. In the case of 99mTc extraction experiment, we used the stock solution included 9 MBq of Na99mTcO4 solution. 99mTc concentration was measured the organic phases by γ-counter. The ratio of aqueous and organic phases was 1:1, respectively.

Results The Mo concentrations of MEK and other organic phases were ca. 22 ppm and less than 2 ppm after extraction (2 ppm was limitation). 99mTc yield was 0.84 in MEK, however its yields were less than 0.1 in other organic solvent. The yields were 0.066 in ethyl acetate, 0.051 in chloroform, 0.005 in carbon tetrachloride, 0.001 in dichloromethane, and less than 0.001 in hexane and diethyl ether.

Conclusions MEK is good extracting solvent to 99mTc, however Mo is also included in extracted solvent. In the future, we have to optimize the method to remove Mo in MEK, or search the solvent which extracts 99mTc efficiently and decreases mixing Mo quantity.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Extraction of technetium-99m by some organic solvents from macro scale molybdenum solution.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Extraction of technetium-99m by some organic solvents from macro scale molybdenum solution.
Hayato Ikeda, Yoshihiko Hayashi, Naruto Takahashi, Kozi Nakai, Atsushi Shinohara, Tadashi Watabe, Yasukazu Kanai, Hiroki Kato, Eku Shimosegawa, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1119;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Extraction of technetium-99m by some organic solvents from macro scale molybdenum solution.
Hayato Ikeda, Yoshihiko Hayashi, Naruto Takahashi, Kozi Nakai, Atsushi Shinohara, Tadashi Watabe, Yasukazu Kanai, Hiroki Kato, Eku Shimosegawa, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1119;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Radiopharmacy Posters

  • Synthesis of [18F]Tetrafluoroborate ([18F]TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model
  • 18F-Sulforhodamine 101 derivative as a potential agent for astrocytosis diagnosis: labelling and preliminary biological studies
  • Clinical FDOPA: its time has come
Show more SPECIAL MTA: Radiopharmacy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire